Use of Symbicort or Pulmicort to Treat Viral-mediated Asthma Exacerbations
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
This is an investigator-initiated study in which Dr. Nadeau wrote the protocol and received
funding from an Astra Zeneca grant to direct, perform, and monitor the study on her own with
Stanford staff. We hypothesize that the budesonide/formoterol combination improves the
efficacy of budesonide alone.
Phase:
N/A
Details
Lead Sponsor:
Stanford University
Collaborator:
AstraZeneca
Treatments:
Budesonide Budesonide, Formoterol Fumarate Drug Combination